Login
Israel-Hamas Conflict
Airstrike
Benjamin Netanyahu
Military
World Cup
Social Media
United Nations
Baseball
Artificial Intelligence
Education
Immigration and Customs Enforcement
Donald Trump
Infrastructure
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Pharmaceutical Business Review image

News from Pharmaceutical Business review

Information about Pharmaceutical Business Review

Where is Pharmaceutical Business Review located?Pharmaceutical Business Review's Website

Media Bias Ratings

Do you diasgree?
Edit bias
Learn more about Media Bias Ratings.

Factuality

Learn more about  Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about  Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top Pharmaceutical Business Review News

Salipro Biotech and Daewoong Pharmaceutical Announce Collaboration Agreement to Advance Development of Novel Therapeutics
Pharma · Burlington

Salipro Biotech and Daewoong Pharmaceutical Announce Collaboration Agreement to Advance Development of Novel Therapeutics

68% Center coverage: 37 sources
The collaboration combines Salipro Biotech's unique expertise and its Salipro® platform technology to stabilize a challenging drug target and advance Daewoong Pharmaceutical's drug discovery programs for the generation of small molecule drugs.See the Story
Alvotech and Dr. Reddy’s Enter into Collaboration to Co-Develop Biosimilar Candidate to ...
Technology

Alvotech and Dr. Reddy’s Enter into Collaboration to Co-Develop Biosimilar Candidate to ...

43% Right coverage: 7 sources
HYDERABAD, India and REYKJAVIK, Iceland, June 05, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide (“Alvotech”), and Dr. Reddy’s Laboratories Ltd., (BSE: 500124See the Story
Following Novo Nordisk, Eli Lilly Lands Partner for R&D of Longer-Acting Metabolic Meds
Eli Lilly

Following Novo Nordisk, Eli Lilly Lands Partner for R&D of Longer-Acting Metabolic Meds

100% Center coverage: 2 sources
Eli Lilly is partnering with Camurus, a company with technology that extends how long an injectable drug lasts in the body, permitting longer dosing intervals. Lilly plans to apply the technology to its metabolic medicines; the deal follows a similar move Novo Nordisk starting an alliance with Ascendis. The post Following Novo Nordisk, Eli Lilly Lands Partner for R&D of Longer-Acting Metabolic Meds appeared first on MedCity News.See the Story

Health Canada authorises Roche’s PiaSky for PNH

PiaSky will be given as the first monthly subcutaneous therapy for adults and adolescents aged 13 years or more with a minimum body weight of 40kg. Patients have The post Health Canada authorises Roche’s PiaSky for PNH appeared first on Pharmaceutical Business review.Health Canada · CanadaRead Article

Monte Rosa Therapeutics receives FDA clearance for MRT-8102 IND

MRT-8102 is a NEK7-directed molecular glue degrader being developed to treat inflammatory diseases driven by the NLRP3 inflammasome and IL-1β. Monte Rosa Therapeutics CEO Markus Warmuth said: “The The post Monte Rosa Therapeutics receives FDA clearance for MRT-8102 IND appeared first on Pharmaceutical Business review.United States · United StatesRead Article

Neowise and BeOne Medicines sign agreement for cell therapy

Under the agreement, Neowise will be eligible for an upfront payment and will also receive future milestone payments. These payments are contingent upon reaching specific development, regulatory, and The post Neowise and BeOne Medicines sign agreement for cell therapy development appeared first on Pharmaceutical Business review.Read Article

Italfarmaco’s Duvyzat gains EC conditional approval for DMD treatment

Duvyzat must be administered alongside corticosteroids and is not limited by the patient’s specific genetic mutation. The decision is applicable across all 27 EU member states, as well The post Italfarmaco’s Duvyzat gains EC conditional approval for DMD treatment appeared first on Pharmaceutical Business review.Read Article

Real-World Study Illuminates Waldenstrom Macroglobulinemia Outcomes

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted precision medicine strategies.United States · United StatesSee the Story

Zealand Pharma submits glepaglutide MAA for short bowel syndrome

Glepaglutide is intended for administering two times a week for SBS. The application is based on results from the pivotal Phase III clinical trial EASE-1, supported by interim The post Zealand Pharma submits glepaglutide MAA for short bowel syndrome appeared first on Pharmaceutical Business review.Denmark · DenmarkRead Article

Mabwell’s Mailisheng receives NMPA marketing approval

The company’s wholly owned subsidiary T-mab developed the drug. It is Mabwell’s first commercialised innovative drug, and the first introduced granulocyte colony-stimulating factor (G-CSF) developed with albumin long-acting The post Mabwell’s Mailisheng receives NMPA marketing approval appeared first on Pharmaceutical Business review.China · ChinaRead Article

WisBusiness: Archeus Technologies, WARF launching clinical trial this year for cancer targeting molecule - Wisconsin Technology Council

Archeus Technologies in Madison and WARF are launching a clinical trial this year for a targeting molecule used in treating prostate cancer. The organizations yesterday announced the plans to further develop ART-101, a receptor-based targeting molecule developed at UW-Madison’s Advanced Radiotheranostics lab. It’s designed to deliver radioactive isotopes within the body as part of aCancer · MadisonSee the Story

Breaking News Topics Related to Pharmaceutical Business Review

United States

United States

Medical

Medical

Canada

Canada

Cancer

Cancer

News
For You
SearchBlindspotLocal